Pars Isotope’s participation in the 39th Brazilian Congress of Nuclear Medicine

Pars Isotope will participate in the 39th Brazilian Congress of Nuclear Medicine and Molecular Imaging (CBMN), to be held from August 22 to 24, 2025, in Belo Horizonte, Brazil.

CBMN, organized by the Brazilian Society of Nuclear Medicine, will be a prestigious scientific event and one of the most important academic gatherings in the field of molecular imaging and theranostics. It will host leading experts, researchers, and companies from around the world and across Latin America.

Among the most significant achievements to be discussed at this scientific congress are:
•Introduction of the new generation of therapeutic and diagnostic radiopharmaceuticals
•Increased production capacity to meet international market demands
•Advancements in molecular imaging and theranostics technologies
•Enhanced research collaborations with nuclear and medical centers across Latin America

On the sidelines of the congress, an exhibition will be held where Pars Isotope, as the sole Iranian producer of diagnostic and therapeutic radiopharmaceuticals, will be among the exhibitors. In recent years, Pars Isotope has focused particularly on expanding exports of radiopharmaceutical kits to South American countries, successfully establishing its position as a reliable supplier in this market. Participation in CBMN 2025 represents a strategic step towards developing these collaborations and building a broader network of scientific, medical and industrial partners across the region.